Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer

Thierry Bury, Ana Terra Fonseca Barreto(University of Liège), Frédéric Daenen(Centre Hospitalier Universitaire de Liège), Nicole Barthélémy(University of Liège), B. Ghaye(Centre Hospitalier Universitaire de Liège), P. Rigo(Centre Hospitalier Universitaire de Liège)

European Journal of Nuclear Medicine and Molecular Imaging

September 1, 1998

10.1007/s002590050291

Cited by 315Open Access

Abstract

Related Papers

THE METABOLISM OF TUMORS IN THE BODY

Otto Warbürg, Franz Wind, Erwin Negelein|The Journal of General Physiology|1927|4.3k

A FLUORINATED GLUCOSE ANALOG, 2-FLUORO-2-DEOXY-D-GLUCOSE (F-18)

P. Som, Harold Atkins, D. Bandoypadhyay et al.|Journal of Computer Assisted Tomography|1980|503

Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose

P. Rigo, Patrick Paulus, Bruno Kaschten et al.|European Journal of Nuclear Medicine and Molecular Imaging|1996|502

Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation.

Richard L. Wahl, Leslie E. Quint, Robert Greenough et al.|Radiology|1994|430

Staging non—small cell lung cancer by whole-body positron emission tomographic imaging

Peter E. Valk, Thomas R. Pounds, Donald M. Hopkins et al.|The Annals of Thoracic Surgery|1995|318